Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model.

[1]  N. Mackman,et al.  Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury. , 2003, The Annals of thoracic surgery.

[2]  J. Arnout,et al.  Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. , 2002, The Journal of thoracic and cardiovascular surgery.

[3]  K. Schechtman,et al.  Role of tissue factor-mediated coagulation in ischemia/reperfusion-induced injury of Langendorf-perfused rabbit hearts , 2000, Coronary artery disease.

[4]  M. Czerny,et al.  Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  C. Esmon.  Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? , 2000, Blood.

[6]  J. Hansen,et al.  Heparin blunts endotoxin-induced coagulation activation. , 1999, Circulation.

[7]  J. Paramo,et al.  Effect of the administration of recombinant hirudin and/or tissue‐plasminogen activator (t‐PA) on endotoxin‐induced disseminated intravascular coagulation model in rabbits , 1999, British journal of haematology.

[8]  C. Tetik,et al.  Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats , 1999, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[9]  H. Yamagishi,et al.  Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat. , 1998, Transplantation.

[10]  J. Vincent,et al.  Gastric mucosal pH is definitely obsolete--please tell us more about gastric mucosal PCO2. , 1998, Critical care medicine.

[11]  T. Brussel,et al.  Continuous intramucosal PCO2 measurement allows the early detection of intestinal malperfusion. , 1998, Critical care medicine.

[12]  J. A. Kruse,et al.  Relationship between systemic oxygen supply dependency and gastric intramucosal PCO2 during progressive hemorrhage. , 1998, The Journal of trauma.

[13]  J. Weitz,et al.  Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors. , 1998, Circulation.

[14]  R. Weintraub,et al.  Low-dose dopexamine's effect on lung and gut function after CPB in a sheep model. , 1998, The Journal of surgical research.

[15]  P. Kubes,et al.  Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. , 1997, Circulation.

[16]  E. Verrier,et al.  The Systemic Inflammatory Response , 1997 .

[17]  E. Verrier,et al.  Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. , 1996, The Annals of thoracic surgery.

[18]  T. Gillebert,et al.  Recovery of Systolic and Diastolic Left Ventricular Function Early after Cardiopulmonary Bypass , 1996, Anesthesiology.

[19]  E. Verrier,et al.  Endothelial cell injury in cardiovascular surgery. , 1996, The Annals of thoracic surgery.

[20]  J. Davis,et al.  The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. , 1996, The Journal of pharmacology and experimental therapeutics.

[21]  A Haverich,et al.  Systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.

[22]  J. Pepper,et al.  The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. , 1995, Chest.

[23]  M. Wolzt,et al.  Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin). , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[24]  F. Spinale,et al.  Direct effects of thrombin on myocyte contractile function. , 1995, The Annals of thoracic surgery.

[25]  V. Fuster,et al.  Persistent Thrombin Generation in Humans During Specific Thrombin Inhibition With Hirudin , 1994, Circulation.

[26]  J. Duranteau,et al.  Heterogeneous regional vascular responses to simulated transient hypovolemia in man , 1994, Intensive Care Medicine.

[27]  S. Ohri,et al.  Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. , 1994, The Annals of thoracic surgery.

[28]  A. Macpherson,et al.  The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. , 1994, Gastroenterology.

[29]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments] , 1993 .

[30]  L. W. Andersen,et al.  Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor‐α concentrations in patients undergoing cardiopulmonary bypass , 1993, Critical care medicine.

[31]  C. Esmon,et al.  Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C , 1991, Thrombosis and Haemostasis.

[32]  J. Kirklin.  Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[33]  D. Massel,et al.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.

[34]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[35]  D. Granger,et al.  Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. , 1988, The American journal of physiology.

[36]  K. Messmer,et al.  Microcirculation in Circulatory Disorders , 1988, Springer Japan.

[37]  The Surgery of the Chest , 1896, The Hospital.

[38]  G. Valen,et al.  Induction of inflammatory mediators during reperfusion of the human heart. , 2001, The Annals of thoracic surgery.

[39]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. , 1993, Blood.

[40]  R. Fiddian-Green.  Assessment of the Adequacy of Mucosal Oxygenation in Patients with Intraluminally Located Silicone Tonomitors , 1988 .

[41]  J. Hansen,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Lepirudin blunts endotoxin-induced coagulation activation , 2022 .